Advantagene, Inc. — Form D
Advantagene, Inc. of AUBURNDALE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-26. The offering totals $28.7M, of which $28.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-26
- Form: D
- Accession: 0001660549-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $28.7M
- Amount sold: $28.7M
- Investors: 18
- Date of first sale: 2018-11-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-326482
Issuer
- Name: Advantagene, Inc.
- CIK: 0001660549
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 440 LEXINGTON STREET, AUBURNDALE, MA, 02466
- Phone: 617-916-5445
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Estuardo Aguilar-Cordova | Director | Auburndale, MA |
| Edward J Benz | Director | Greenwich, CT |
| Paul C Manning | Director | Auburndale, MA |
| Chris C Martell | Director | Auburndale, MA |
| Udi C Merav | Director | Auburndale, MA |
| Alan C Smith | Director | Auburndale, MA |
| Sean C Stalfort | Director | Auburndale, MA |
| Laura Aguilar | Executive Officer | Auburndale, MA |
| Estuardo Aguilar-Cordova | Executive Officer | Auburndale, MA |
| Stephen C Rocamboli | Executive Officer | Hummelstown, PA |
| Glenn C Mattes | Director | Auburndale, MA |
| Mitchell C Finer | Director | Auburndale, MA |
| Fred C Mermelstein | Director | Auburndale, MA |
Other filings by this issuer (6)
More